You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Irinotecan

Showing 1 - 25 of 1,952
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Peritoneal Metastases Trial in Eindhoven, Rotterdam (Irinotecan, FOLFOX regimen, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Peritoneal Metastases
  • Irinotecan
  • +2 more
  • Eindhoven, Netherlands
  • +1 more
Aug 15, 2023

Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

Recruiting
  • Refractory Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2023

Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab and irinotecan
  • (no location specified)
Jul 26, 2023

Metastatic Colorectal Cancer Trial in Madison (Liposomal irinotecan, TAS102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Liposomal irinotecan
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
May 2, 2023

Small Cell Lung Cancer Trial (SC0245, Irinotecan)

Not yet recruiting
  • Small Cell Lung Cancer
  • (no location specified)
Feb 7, 2023

Gastric Cancer Trial in Goyang (CKD-702 in combination with irinotecan)

Recruiting
  • Gastric Cancer
  • CKD-702 in combination with irinotecan
  • Goyang, Gyeonggi, Korea, Republic of
    National Cancer Center
Feb 20, 2023

Colorectal Cancer Trial (Tislelizumab, Irinotecan Hydrochloride, cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Mar 23, 2023

Gastric Cancer Trial (Fruquintinib, Irinotecan)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Dec 6, 2022

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Xiao Chai Hu Tang, Irinotecan-induced Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Placebo, FOLFIRI/mXELIRI regimen)

Not yet recruiting
  • Xiao Chai Hu Tang
  • Irinotecan-induced Diarrhea
  • Xiao Chai Hu Tang (XCHT)
  • +3 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Traditional Chinese Medicine
Sep 24, 2023

Advanced Solid Tumors Trial in Guangzhou (JS109 combine with irinotecan)

Recruiting
  • Advanced Solid Tumors
  • JS109 combine with irinotecan
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 9, 2023

Colorectal Cancer Liver Metastases, Regorafenib Trial in Guangdong (Regorafenib and DIBIRI, Regorafenib)

Recruiting
  • Colorectal Cancer Liver Metastases
  • Regorafenib
  • Guangdong, Guangzhou, China
    Bo Zhang
Mar 20, 2023

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

Not yet recruiting
  • Gastric Cancer Stage IV
  • (no location specified)
Nov 13, 2022

Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • (no location specified)
Oct 13, 2023

Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in

Not yet recruiting
  • Pancreatic Adenocarcinoma Metastatic
    • Pessac, France
      CHU Bordeaux
    Aug 17, 2023

    Advanced Colorectal Cancer Trial in Guangzhou

    Recruiting
    • Advanced Colorectal Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Feb 7, 2023

      RWE on mPDAC Long-term Survival After Treatment With Liposomal

      Recruiting
      • Pancreatic Cancer Metastatic
        • Munich, Germany
          Klinikum der Universität München, - Anstalt des öffentlichen Rec
        Nov 24, 2023

        Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)

        Not yet recruiting
        • Colon Cancer
        • Colorectal Cancer
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 1, 2023

        Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)

        Not yet recruiting
        • Small Cell Lung Cancer
        • +2 more
        • (no location specified)
        Nov 27, 2022

        Second Line Treatment of Gastric Cancer Trial (Camrelizumab, Albumin-Bound Paclitaxel, Irinotecan)

        Not yet recruiting
        • Second Line Treatment of Gastric Cancer
        • (no location specified)
        Dec 20, 2022

        Colorectal Cancer Trial in Shanghai (FOLFIRI+Bevacizumab)

        Recruiting
        • Colorectal Cancer
        • Shanghai, Pudong, China
          Affiliated Cancer Hospital of Fudan University
        Jul 24, 2023

        Colorectal Cancer Liver Metastasis Trial (Irinotecan and polyvinyl alcohol sodium acrylate embolization

        Not yet recruiting
        • Colorectal Cancer Liver Metastasis
        • Irinotecan and polyvinyl alcohol sodium acrylate embolization microspheres（Unipearls®）
        • Irinotecan and HepaSphere Microspheres
        • (no location specified)
        Aug 31, 2023

        Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

        Not yet recruiting
        • Metastatic Solid Tumor
        • +4 more
        • San Francisco, California
          University of California, San Francisco
        Jan 12, 2023

        Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)

        Completed
        • Objective Response
        • Overall Survival
        • VIA combination treatment
        • Beijing, China
          Peking University People's Hospital
        Dec 9, 2022